预测修改策略的时间趋势和医院水平变化 通过皮肤冠状动脉干预的采用策略
Omar M Abdelfattah1, Omar Chaabo2, Joe Aoun2
1Department of Cardiovascular Medicine, Sealy Heart & Vascular Institute, University of Texas Medical Branch, Galveston, Texas, USA.
JACC. Advances
|October 8, 2025
概括
预计到2035年,静脉内 (IVL) 的采用率将大大超过冠状动脉切除术 (CA). 这一趋势对心血管干预资源分配和患者护理策略具有关键影响.
科学领域:
- 心血管干预 心血管干预
- 采用健康技术 采用健康技术
- 医学经济学 医学经济学
背景情况:
- 新型心血管干预技术显著影响患者护理和资源配置.
- 了解采用模式对于医疗保健的战略规划至关重要.
- 这项研究比较了静脉内石 (IVL) 和冠状动脉切除术 (CA) 的采用趋势.
研究的目的:
- 预测到2035年各种修饰策略,特别是IVL和CA的利用趋势.
- 分析预计的采用率,并确定医疗保健机构的潜在差异.
主要方法:
- 使用了2009-2022年美国注册表数据.
- 采用蒙特卡洛模拟 (100,000 次代) 来建模采用和医院级变异.
- 应用后勤增长模型用于到2035年的技术采用预测.
主要成果:
- 预计到2035年,IVL采用率将达到32.41%的终端率,平均年增长率为2.5%.
- 冠状动脉切除术 (CA) 的采用率预计将显著下降,到2035年达到4.5%至5.5%.
- 观察到采用模式的变化越来越多,大批量中心显示CA使用的增加.
结论:
- 与CA相比,IVL表现出明显更快的采用率.
- 不同的采用模式需要临床实践,资源配置和卫生政策的战略规划.
- 研究结果强调了心血管干预技术的不断发展.
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
389
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
389
Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Acute Coronary Syndrome IV: Interprofessional Care
219
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219
Angina IV: Management
236
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
236
Cardiac Catheterization I: Pre-Procedure Overview
1.1K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.1K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.3K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K


